Organon & Co.: Pay

Organon & Co. paid its 6 named executives $38.2M in total in FY2025 (Dec). CEO Joseph Morrissey was paid $5.8M of that.

PayNo stock prices for these years
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Kevin AliFormer Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Joseph MorrisseyInterim Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Matthew WalshEVP and Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Juan Camilo Arjona Ferreira, M.D.EVP and Head of R&D and Chief Medical Officer
FY2025 (Dec)
1 year
Rachel StahlerEVP and Chief Digital & Growth Officer
FY2025 (Dec)
1 year
Kirke WeaverEVP, General Counsel and Corporate Secretary
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)
3 years

CEO pay against the pay peers

In FY2024 (Dec), the median CEO pay of the 13 peers with pay on file was $17.2M. The CEO of Organon & Co. was paid $17.1M, 1% below the median.

  1. 1Iqvia Holdings
  2. 2Biogen
  3. 3Boston Scientific
  4. 4Intuitive Surgical
  5. 5Baxter International
  6. 6Becton Dickinson & Co
  7. 7Zoetis
  8. 8Organon & Co.
  9. 9Bausch Health Companies
  10. 10Elanco Animal Health
  11. 11Viatris
  12. 12Edwards Lifesciences
  13. 13Revvity
  14. 14Regeneron Pharmaceuticals
  15. 15Agilent TechnologiesNot disclosed
  16. 16AvantorNot disclosed
  17. 17Catalent, Inc.Not disclosed
  18. 18Hologic, Inc.Not disclosed
  19. 19PERRIGO CoNot disclosed
  20. 20Vertex PharmaceuticalsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.